Literature DB >> 3898826

Potassium supplementation via the dialysate in continuous ambulatory peritoneal dialysis.

A Spital, R H Sterns.   

Abstract

A small percentage of patients treated with continuous ambulatory peritoneal dialysis (CAPD) may become hypokalemic. Since both the intravenous and oral routes for potassium repletion have disadvantages, we studied the feasibility, effectiveness, and safety of acute potassium loading via the dialysate in patients on CAPD. Five patients were studied during an exchange containing 20 mEq/L of potassium. This was well tolerated and led to a gradual increase in the plasma potassium concentration (.44 +/- .11 mEq/L) as about three-fourths of the intraperitoneal load was absorbed, most of it by two hours. The greatest increase in the plasma potassium concentration was .63 mEq/L. A separate patient developed intense abdominal pain during an exchange containing 40 mEq/L of potassium. We conclude that the dialysate is a safe and effective route for acute potassium repletion during CAPD when the dialysate potassium concentration does not exceed 20 mEq/L.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3898826     DOI: 10.1016/s0272-6386(85)80022-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  13 in total

Review 1.  Prevalence and pathogenesis of hypokalemia in patients on chronic peritoneal dialysis: one center's experience and review of the literature.

Authors:  Effie Tziviskou; Carlos Musso; Vincenzo Bellizzi; Mukesh Khandelwal; Tao Wang; Shokoufeh Savaj; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

2.  Severe hyperkalemia in a peritoneal dialysis patient after consumption of salt substitute.

Authors:  Terence Yip; Winnie Wan; Pui-Chi Hui; Sing-Leung Lui; Wai-Kei Lo
Journal:  Perit Dial Int       Date:  2012 Mar-Apr       Impact factor: 1.756

3.  Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort.

Authors:  Klara Torlén; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Tania Vashistha; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 8.237

4.  Long-term effects of spironolactone in peritoneal dialysis patients.

Authors:  Yasuhiko Ito; Masashi Mizuno; Yasuhiro Suzuki; Hirofumi Tamai; Takeyuki Hiramatsu; Hiroshige Ohashi; Isao Ito; Hirotake Kasuga; Masanobu Horie; Shoichi Maruyama; Yukio Yuzawa; Tatsuaki Matsubara; Seiichi Matsuo
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

5.  Comparison of Icodextrin and 2.5% Glucose in Potassium Metabolism by Acute K load via Dialysate in Continuous Ambulatory Peritoneal Dialysis Patients.

Authors:  Joo-Hark Yi; Yeo-Wook Yun; Sang-Woong Han; Ho-Jung Kim
Journal:  Electrolyte Blood Press       Date:  2009-06-30

6.  Icodextrin improves the serum potassium profile with the enhancement of nutritional status in continuous ambulatory peritoneal dialysis patients.

Authors:  Joo-Hark Yi; Jae-Il Park; Hoon-Young Choi; Ho-Yung Lee; Sang-Woong Han; Ho-Jung Kim
Journal:  Electrolyte Blood Press       Date:  2009-12-31

7.  De novo hypokalemia in incident peritoneal dialysis patients: a 1-year observational study.

Authors:  Ji Yong Jung; Jae Hyun Chang; Hyun Hee Lee; Wookyung Chung; Sejoong Kim
Journal:  Electrolyte Blood Press       Date:  2009-12-31

8.  Lower serum potassium associated with increased mortality in dialysis patients: A nationwide prospective observational cohort study in Korea.

Authors:  Sunhwa Lee; Eunjeong Kang; Kyung Don Yoo; Yunhee Choi; Dong Ki Kim; Kwon Wook Joo; Seung Hee Yang; Yong-Lim Kim; Shin-Wook Kang; Chul Woo Yang; Nam Ho Kim; Yon Su Kim; Hajeong Lee
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

9.  Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.

Authors:  Amit Langote; Swapnil Hiremath; Marcel Ruzicka; Brendan B McCormick
Journal:  PLoS One       Date:  2017-11-10       Impact factor: 3.240

10.  Time-averaged serum potassium levels and its fluctuation associate with 5-year survival of peritoneal dialysis patients: two-center based study.

Authors:  Shen-Heng Li; Jian-Teng Xie; Hai-Bo Long; Jun Zhang; Wei-Dong Zhou; Hong-Xin Niu; Xun Tang; Zhong-Lin Feng; Zhi-Ming Ye; Yang-Yang Zuo; Lei Fu; Feng Wen; Li-Ping Wang; Wen-Jian Wang; Wei Shi
Journal:  Sci Rep       Date:  2015-10-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.